ArticleJournal of the Endocrine Society2022

Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas.

Lauren Hassan Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.